Rat Anti-Mouse VEGFR-2/KDR, Antagonistic
Slide this table
Cat-Nr. | mV1001.1r-m |
Size | 100 µg |
Price | 625 € |
Category | Monoclonal Antibody |
Clone Nr. | (#MAB0701) |
Isotype | IgG1 |
Species Reactivity | Mouse |
Formulation | lyophilized |
Buffer | PBS |
Reconstitution | Centrifuge the vial prior to opening. Reconstitute the antibody with 200 µl sterile PBS and the final concentration is 500 µg/ml. |
Stability and Storage | Lyophilized samples are stable for 2 years from date of receipt when stored at -20°C. Reconstituted antibody can be aliquoted and stored frozen at < -20°C for at least six months without detectable loss of activity. |
Preparation | This antibody was produced from a hybridoma (mouse myeloma fused with spleen cells from a rat) immunized with purified mouse VEGFR2 extracellular domain |
Antigen | mouse VEGFR2 extracellular domain |
Application | WB, Attenuation of VEGF-induced KDR tyrosine phosphorylation, IP |
Synonyms | vascular endothelial growth factor receptor-2 ; Kdr; Ly73; Flk-1; VEGFR2; VEGF receptor 2; kinase insert domain protein receptor |
Description | VEGF R1 (Flt-1), VEGF R2 (KDR/Flk-1), and VEGF R3 (Flt-4) belong to the class III subfamily of receptor tyrosine kinases (RTKs). All three receptors contain seven immunoglobulin-like repeats in their extracellular domain and kinase insert domains in their intracellular region. They are best known for regulating VEGF family-mediated vasculogenesis, angiogenesis, and lymphangiogenesis. They are also mediators of neurotrophic activity and regulators of hematopoietic development. Human VEGF R2 is thought to be the primary inducer of VEGF-mediated blood vessel growth, while VEGF R3 plays a significant role in VEGF-C and VEGF-D-mediated lymphangiogenesis. The antibody will bind near the ligand binding site of the receptor and has antagonistic activity by blocking the binding of natural ligands. |
Uniprot ID | P35918 |
Protein RefSeq | ACJ66293.1 |
mRNA RefSeq | EU884114 |
All prices plus VAT + possible delivery charges